MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) has reported its financial results for the third quarter of 2024, highlighting ...
In the NBA and sports in general, retirement is a strange and challenging phase. After years of dedicating every single day ...
In good news for those averse to injections, GLP-1 agonist medication is a step closer to being offered in oral pill form, ...